Relevance. In today's world, the attention of health professionals in each country is focused on the outbreak of acute respiratory disease, called coronavirus disease in 2019 - COVID-19. Today there is an increase in the incidence of this disease both in Ukraine and abroad, the disease is more severe, mortality has increased and the percentage of diseases among children has increased.
Objective іs to analyze the clinical and epidemiological features of COVID-19 in Bukovina.
Materials and methods. A retrospective analysis of medical histories of patients with confirmed diagnosis of COVID-19, who were hospitalized in the infectious department of OKNP "Chernivtsi Regional Clinical Hospital".
Results. The age of patients ranged from 22 to 79 years; the average age is 53.6 years. There were 35 men and 30 women (53.8 and 46.2%, respectively). In most patients the course of the disease was moderate, and only 6% of patients had a severe course of the disease. Each hospitalized patient had bronchial and pulmonary lesions, which were confirmed radiologically and by computed tomography (CT). The structure of diagnosed pneumonia was dominated by bilateral lung damage (98.3%). Symptoms of gastrointestinal lesions were noted in 11 patients (16.9%).
Conclusions. According to our observations, we can conclude that susceptibility to a new coronavirus infection is common. However, the elderly, as well as patients with comorbidities, are more likely to develop severe symptoms and higher mortality. Patients at risk with severe course (6%) required special attention. In the early stages of the disease, the use of minimal respiratory support through oxygen therapy is justified.
Zadorozhna VI, Vynnyk NP. [Coronavirus 2019-nCOV: new challenges for health and humanity]. Infectious diseases. 2020; 1(99): 5-15. [in Ukrainian]. DOI https://doi.org/10.11603/1681-2727.2020.1
Publisher site: https://ojs.tdmu.edu.ua/index.php/inf-patol/issue/view/638
A World at risk: Annual report on global preparedness for health emergencies. Global Preparedness Monitoring Board. 2019.
Chan J.F.-W., Kok K.-H., Zhu Z., Chu H., To K.K.-W., Yuan S., Yuen K.-Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020; 9(1): 221-36. DOI: 10.1080/22221751.2020.1719902
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067204/
WHO: New case of laboratory-confirmed SARS in Guangdong, China – update 5. – 31 January 2004.
Publisher site: https://www.who.int/csr/don/2004_01_31/en/
WHO: MERS situation update. – December 2019.
WHO: Novel сoronavirus – China (Disease outbreak news: Update 12 January 2020).
Publisher site: https:// www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
Zhao S., Musa S.S., Lin Q. Ran J., Yang G, Wang W., Lou Y., Yang L., Gao D., He D., Wang M.H. Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. J. Clin. Med. 2020; 9(2):E388. DOI: 10.3390/jcm9020388.
Publisher site: https://www.mdpi.com/2077-0383/9/2/388
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074332/
WHO: Novel Coronavirus – Japan (ex-China) (Disease outbreak news: 16 January 2020. Electronic resource.
Lu R., Zhao X., Li J. [et al.] Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 January; 395(10224). DOI: 10.1016/S0140-6736(20)30251-8
Publisher site: https://www.thelancet.com/article/S0140-6736(20)30251-8/fulltext
Guan W., Ni Z., Hu Y. [et al.] Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020. DOI: 10.1101/2020.02. 06.20020974
Publisher site: https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1
Europe PMC: https://europepmc.org/article/ppr/ppr112207
Wang D., Hu B., Hu Ch., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Zh., Xiong Y., Zhao Y., Li Y., Wang X., Peng Zh. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323(11):1061-9. DOI:10.1001/jama.2020.1585
Publisher site: https://jamanetwork.com/journals/jama/fullarticle/2761044
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042881/
Huang C., Wang Y., Li X. [et al.] Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. DOI: 10.1016/S0140-6736(20)30183-5
Zhang H., Kang Z.J., Gong H.Y., Xu D, Wang J, Li Z, Cui X, Xiao J, Meng T, Zhou W, Liu J, Xu H. The digestive system is a potential route of 2019 nCoV infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020. DOI: 10.1101/2020.01.30.927806
Publisher site: https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1
Holshue M.L., DeBolt C., Lindquist S. [et al.] First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020 Mar 5;382(10):929-36. DOI: 10.1056/NEJMoa2001191.
Publisher site: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092802/
Zhao Y., Zhao Z., Wang Y. Zhou Y., Ma Y., Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. medRxiv. 2020 January 26. DOI: 10.1101/2020.01.26.919985
Publisher site: https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1
Linton N.M., Kobayashi T., Yang Y., Hayashi K., Akhmetzhanov AR., Jung S-M, Yuan B., Kinoshita R., Nishiura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data. J. Clin. Med. 2020; 9(2): 538. DOI: 10.3390/jcm9020538
Publisher site: https://www.mdpi.com/2077-0383/9/2/538
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074197/
Backer J.A., Klinkenberg D., Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January. Euro Surveill. 2020 Feb; 25(5):2000062. DOI: 10.2807/1560-7917.ES.2020.25.5.2000062
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014672/
Tracking coronavirus: Map, data and timeline. BNO Neus. 2020.
COVID-19 Coronavirus Outbreak. Last updated: February 22, 2020.
Publisher site: https://www. worldometers.info/coronavirus
Riou J., Althaus C.L. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020; 25(4):2000058. DOI: 10.2807/1560-7917.ES.2020.25.4.2000058.
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001239/
Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection. 2020 March; 104(Issue 3): 246-51. DOI: 10.1016/j.jhin.2020.01.022
Agostini M.L., Andres E.L., Sims A.C. [et al.] Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018 March; 9(2): e00221-18. DOI: 10.1128/mBio.00221-18.
Publisher site: https://mbio.asm.org/content/9/2/e00221-18
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844999/
Beck B.R., Shin B., Choi Y., Park S., Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020 February. DOI: 10.1101/2020.01.31.929547
Publisher site: https://www.biorxiv.org/content/10.1101/2020.01.31.929547v1
Jiang S., Du L., Shi Z. An emerging coronavirus caus/ng pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerging Microbes & Infections. 2020 Jan 31; 9(1): 275-7. DOI: 10.1080/22221751.2020.1723441
PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033706/
Coppo A, Bellani G, Winterton D, [et al]. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020; S2213- 2600(20)30268-X. DOI:10.1016/S2213-2600(20)30268-X
This work is licensed under a Creative Commons Attribution 4.0 International License.